Rank | Gene Set | Z-score |
---|---|---|
1 | activated T cell proliferation (GO:0050798) | 3.77258489 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66876657 |
3 | modulation by symbiont of host defense response (GO:0052031) | 3.66876657 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66876657 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66876657 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66876657 |
7 | modulation by symbiont of host immune response (GO:0052553) | 3.66876657 |
8 | synaptic vesicle maturation (GO:0016188) | 3.66217682 |
9 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65531851 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.60110661 |
11 | regulation of ARF protein signal transduction (GO:0032012) | 3.54448849 |
12 | B cell receptor signaling pathway (GO:0050853) | 3.48664066 |
13 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.48197216 |
14 | macrophage activation involved in immune response (GO:0002281) | 3.43990232 |
15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.41053728 |
16 | sodium ion export (GO:0071436) | 3.40157348 |
17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38843484 |
18 | negative regulation of cell killing (GO:0031342) | 3.38843484 |
19 | detection of other organism (GO:0098543) | 3.37415783 |
20 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.31966499 |
21 | detection of bacterium (GO:0016045) | 3.31023993 |
22 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.30233792 |
23 | microglial cell activation (GO:0001774) | 3.23755104 |
24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.21105976 |
25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19621276 |
26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.19621276 |
27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19484794 |
28 | potassium ion import (GO:0010107) | 3.18906825 |
29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13367724 |
30 | activation of protein kinase A activity (GO:0034199) | 3.13353052 |
31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12817040 |
32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.12299397 |
33 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.11035425 |
34 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09027933 |
35 | cellular potassium ion homeostasis (GO:0030007) | 3.07109618 |
36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05366524 |
37 | leukocyte aggregation (GO:0070486) | 3.04897564 |
38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.04700758 |
39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04052717 |
40 | locomotory exploration behavior (GO:0035641) | 3.00955245 |
41 | phospholipid dephosphorylation (GO:0046839) | 2.96549183 |
42 | protein targeting to Golgi (GO:0000042) | 2.95757419 |
43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95528824 |
44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.94796049 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.89920635 |
46 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.85027681 |
47 | regulation of beta-amyloid formation (GO:1902003) | 2.82736454 |
48 | cellular extravasation (GO:0045123) | 2.82569252 |
49 | regulation of B cell differentiation (GO:0045577) | 2.81726526 |
50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.76583421 |
51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76196235 |
52 | positive regulation of B cell differentiation (GO:0045579) | 2.74665485 |
53 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.74475671 |
54 | regulation of synaptic vesicle transport (GO:1902803) | 2.74459281 |
55 | germinal center formation (GO:0002467) | 2.73291041 |
56 | synaptic vesicle exocytosis (GO:0016079) | 2.71434909 |
57 | negative thymic T cell selection (GO:0045060) | 2.70941162 |
58 | negative T cell selection (GO:0043383) | 2.69074385 |
59 | detection of external biotic stimulus (GO:0098581) | 2.68962898 |
60 | glutamate secretion (GO:0014047) | 2.68711430 |
61 | macrophage activation (GO:0042116) | 2.67399603 |
62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64636566 |
63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64108201 |
64 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.62741191 |
65 | mannose metabolic process (GO:0006013) | 2.62119918 |
66 | tolerance induction (GO:0002507) | 2.61633765 |
67 | establishment of protein localization to Golgi (GO:0072600) | 2.60867391 |
68 | neutrophil activation involved in immune response (GO:0002283) | 2.60635033 |
69 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.59901985 |
70 | regulation of synapse structural plasticity (GO:0051823) | 2.57468426 |
71 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.57297600 |
72 | negative regulation of B cell mediated immunity (GO:0002713) | 2.57297600 |
73 | response to interleukin-15 (GO:0070672) | 2.57022849 |
74 | negative regulation of type 2 immune response (GO:0002829) | 2.56694011 |
75 | regulation of granulocyte differentiation (GO:0030852) | 2.53607492 |
76 | proline transport (GO:0015824) | 2.53250928 |
77 | neutrophil activation (GO:0042119) | 2.51912068 |
78 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51744220 |
79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51744220 |
80 | negative regulation of adaptive immune response (GO:0002820) | 2.50468023 |
81 | myeloid cell activation involved in immune response (GO:0002275) | 2.49871473 |
82 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.48571822 |
83 | T cell selection (GO:0045058) | 2.48495752 |
84 | T cell migration (GO:0072678) | 2.47748383 |
85 | oxygen transport (GO:0015671) | 2.47109743 |
86 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.46418284 |
87 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45936795 |
88 | thymic T cell selection (GO:0045061) | 2.45106938 |
89 | membrane depolarization during action potential (GO:0086010) | 2.43348353 |
90 | regulation of gamma-delta T cell activation (GO:0046643) | 2.43181830 |
91 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.42468821 |
92 | negative regulation of interleukin-12 production (GO:0032695) | 2.42439549 |
93 | relaxation of cardiac muscle (GO:0055119) | 2.41494563 |
94 | regulation of mast cell degranulation (GO:0043304) | 2.40715582 |
95 | response to muramyl dipeptide (GO:0032495) | 2.38946841 |
96 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.37517964 |
97 | cellular response to epinephrine stimulus (GO:0071872) | 2.37499378 |
98 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.37454883 |
99 | signal complex assembly (GO:0007172) | 2.36792460 |
100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36595154 |
101 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36403716 |
102 | positive T cell selection (GO:0043368) | 2.35028797 |
103 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.35019967 |
104 | neurotransmitter secretion (GO:0007269) | 2.34961269 |
105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.34056484 |
106 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.34056484 |
107 | positive thymic T cell selection (GO:0045059) | 2.34012568 |
108 | gas transport (GO:0015669) | 2.33705624 |
109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.33573140 |
110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.33513012 |
111 | response to host immune response (GO:0052572) | 2.33513012 |
112 | regulation of tolerance induction (GO:0002643) | 2.32599101 |
113 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.32015185 |
114 | vocalization behavior (GO:0071625) | 2.31926278 |
115 | regulation of T cell tolerance induction (GO:0002664) | 2.31277709 |
116 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.31231870 |
117 | respiratory burst (GO:0045730) | 2.30947251 |
118 | immunoglobulin mediated immune response (GO:0016064) | 2.30729362 |
119 | positive regulation of mast cell activation (GO:0033005) | 2.30004428 |
120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28803385 |
121 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.28136320 |
122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.27993569 |
123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.27982030 |
124 | detection of molecule of bacterial origin (GO:0032490) | 2.27956621 |
125 | positive regulation of Rap GTPase activity (GO:0032854) | 2.27624798 |
126 | regulation of germinal center formation (GO:0002634) | 2.27563407 |
127 | detection of biotic stimulus (GO:0009595) | 2.27341177 |
128 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.25967531 |
129 | cell communication by electrical coupling (GO:0010644) | 2.23701835 |
130 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.23263861 |
131 | long-term synaptic potentiation (GO:0060291) | 2.22680299 |
132 | neuronal action potential propagation (GO:0019227) | 2.21283949 |
133 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.21100872 |
134 | growth hormone receptor signaling pathway (GO:0060396) | 2.20167766 |
135 | Golgi to endosome transport (GO:0006895) | 2.19269466 |
136 | mitochondrion distribution (GO:0048311) | 2.19215735 |
137 | glycine transport (GO:0015816) | 2.18587967 |
138 | detection of calcium ion (GO:0005513) | 2.15543273 |
139 | striatum development (GO:0021756) | 2.14227418 |
140 | fibroblast migration (GO:0010761) | 2.14199911 |
141 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.14004985 |
142 | long-term memory (GO:0007616) | 2.13897755 |
143 | positive regulation of cation channel activity (GO:2001259) | 2.13633369 |
144 | regulation of Rap GTPase activity (GO:0032317) | 2.12154099 |
145 | negative regulation of hormone metabolic process (GO:0032351) | 2.10165503 |
146 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.10165503 |
147 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.09110167 |
148 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.08760549 |
149 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.08070556 |
150 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.06687702 |
151 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.06402255 |
152 | cellular response to interleukin-15 (GO:0071350) | 2.06111407 |
153 | cellular sodium ion homeostasis (GO:0006883) | 2.05348562 |
154 | cell communication involved in cardiac conduction (GO:0086065) | 2.05146681 |
155 | succinate metabolic process (GO:0006105) | 2.04985880 |
156 | membrane repolarization (GO:0086009) | 2.04314033 |
157 | stress fiber assembly (GO:0043149) | 2.03839509 |
158 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.03484230 |
159 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.03484230 |
160 | long term synaptic depression (GO:0060292) | 2.03463056 |
161 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.01134603 |
162 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.00634119 |
163 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.99428708 |
164 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.98958231 |
165 | regulation of ARF GTPase activity (GO:0032312) | 1.98931608 |
166 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 1.98897207 |
167 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 1.98854471 |
168 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 1.98455203 |
169 | nerve growth factor signaling pathway (GO:0038180) | 1.97733729 |
170 | negative regulation of stress fiber assembly (GO:0051497) | 1.97692458 |
171 | prepulse inhibition (GO:0060134) | 1.97086646 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27575719 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.51319920 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.28733568 |
4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24422257 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17454125 |
6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09021149 |
7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04487337 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99830487 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88834120 |
10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75806628 |
11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75675460 |
12 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73189980 |
13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72358563 |
14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70225471 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65451463 |
16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64373575 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61251413 |
18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60438588 |
19 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58428500 |
20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57594244 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56838386 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53826358 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 1.48771166 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 1.45372175 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43886516 |
26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42939411 |
27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40100010 |
28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39704495 |
29 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38675702 |
30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37993086 |
31 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36821580 |
32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36685180 |
33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36178677 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35638658 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33460280 |
36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32506522 |
37 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32359091 |
38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32053739 |
39 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31729831 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30910678 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30378551 |
42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28953951 |
43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27572952 |
44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26276437 |
45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26260817 |
46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25955654 |
47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25246955 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.25085761 |
49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24503342 |
50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24394455 |
51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24325662 |
52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23013720 |
53 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22351755 |
54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21732019 |
55 | MYB_26560356_Chip-Seq_TH1_Human | 1.21644593 |
56 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21035361 |
57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20890037 |
58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20523829 |
59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20086756 |
60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16378854 |
61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16219228 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14906428 |
63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12860815 |
64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12618583 |
65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11754475 |
66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11179150 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09170174 |
68 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.08666926 |
69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08103473 |
70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06670582 |
71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06669553 |
72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06499328 |
73 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06337598 |
74 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06337598 |
75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06277364 |
76 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06217393 |
77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05677359 |
78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05523806 |
79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04873549 |
80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04821180 |
81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04427303 |
82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04247374 |
83 | MYC_22102868_ChIP-Seq_BL_Human | 1.02384060 |
84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01596926 |
85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01589672 |
86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00910071 |
87 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.00598608 |
88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99783644 |
89 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99329299 |
90 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99324835 |
91 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98957280 |
92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98627777 |
93 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98614322 |
94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98226234 |
95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98026060 |
96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97714161 |
97 | AR_19668381_ChIP-Seq_PC3_Human | 0.97190264 |
98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97130822 |
99 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96852161 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96789164 |
101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96658014 |
102 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96247786 |
103 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95911288 |
104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95287890 |
105 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95214906 |
106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94470590 |
107 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93957760 |
108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93838781 |
109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93795486 |
110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93795486 |
111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93576557 |
112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92392128 |
113 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91958416 |
114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91348404 |
115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91063226 |
116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90911225 |
117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89994310 |
118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89801673 |
119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89560963 |
120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88349464 |
121 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.88027453 |
122 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87503007 |
123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86179965 |
124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85776585 |
125 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.85060470 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84301426 |
127 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83936935 |
128 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83679833 |
129 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83375009 |
130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83231561 |
131 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82640769 |
132 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82629345 |
133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82076150 |
134 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81215859 |
135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81067385 |
136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80482763 |
137 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.80439373 |
138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80388579 |
139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80296646 |
140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.79949985 |
141 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.74592810 |
142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74536736 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 3.88313266 |
2 | MP0003436_decreased_susceptibility_to | 2.65103371 |
3 | MP0009780_abnormal_chondrocyte_physiolo | 2.56933833 |
4 | MP0010234_abnormal_vibrissa_follicle | 2.47095781 |
5 | MP0004130_abnormal_muscle_cell | 2.42783921 |
6 | MP0004510_myositis | 2.39662220 |
7 | MP0000013_abnormal_adipose_tissue | 2.25282446 |
8 | MP0005670_abnormal_white_adipose | 2.17146694 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.13535463 |
10 | MP0003045_fibrosis | 2.10232452 |
11 | MP0002166_altered_tumor_susceptibility | 2.10062577 |
12 | MP0001501_abnormal_sleep_pattern | 2.06555022 |
13 | MP0002837_dystrophic_cardiac_calcinosis | 2.04608486 |
14 | MP0003646_muscle_fatigue | 2.04131973 |
15 | MP0002822_catalepsy | 2.04041778 |
16 | MP0008961_abnormal_basal_metabolism | 2.03920721 |
17 | MP0002419_abnormal_innate_immunity | 1.98465591 |
18 | MP0000569_abnormal_digit_pigmentation | 1.94570198 |
19 | MP0005666_abnormal_adipose_tissue | 1.91013263 |
20 | MP0005025_abnormal_response_to | 1.89763138 |
21 | MP0002909_abnormal_adrenal_gland | 1.88468624 |
22 | MP0009046_muscle_twitch | 1.82526188 |
23 | MP0008569_lethality_at_weaning | 1.78596068 |
24 | MP0001986_abnormal_taste_sensitivity | 1.73883238 |
25 | MP0002064_seizures | 1.71682169 |
26 | MP0004484_altered_response_of | 1.71076070 |
27 | MP0009745_abnormal_behavioral_response | 1.70203400 |
28 | MP0005058_abnormal_lysosome_morphology | 1.69580929 |
29 | MP0003300_gastrointestinal_ulcer | 1.63296135 |
30 | MP0000751_myopathy | 1.61480259 |
31 | MP0002006_tumorigenesis | 1.57380883 |
32 | MP0002405_respiratory_system_inflammati | 1.57333397 |
33 | MP0005375_adipose_tissue_phenotype | 1.54291334 |
34 | MP0009785_altered_susceptibility_to | 1.52158845 |
35 | MP0004043_abnormal_pH_regulation | 1.50974077 |
36 | MP0005310_abnormal_salivary_gland | 1.50060267 |
37 | MP0002063_abnormal_learning/memory/cond | 1.49809698 |
38 | MP0001835_abnormal_antigen_presentation | 1.45290899 |
39 | MP0002398_abnormal_bone_marrow | 1.44994827 |
40 | MP0003633_abnormal_nervous_system | 1.43412042 |
41 | MP0003656_abnormal_erythrocyte_physiolo | 1.43293689 |
42 | MP0000716_abnormal_immune_system | 1.43013314 |
43 | MP0004270_analgesia | 1.42767953 |
44 | MP0005535_abnormal_body_temperature | 1.42535386 |
45 | MP0005423_abnormal_somatic_nervous | 1.41128947 |
46 | MP0005671_abnormal_response_to | 1.40430775 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.40159723 |
48 | MP0001765_abnormal_ion_homeostasis | 1.39444926 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.38586977 |
50 | MP0000003_abnormal_adipose_tissue | 1.37502732 |
51 | MP0002272_abnormal_nervous_system | 1.36733040 |
52 | MP0003172_abnormal_lysosome_physiology | 1.35719556 |
53 | MP0004036_abnormal_muscle_relaxation | 1.33428208 |
54 | MP0001790_abnormal_immune_system | 1.32077202 |
55 | MP0005387_immune_system_phenotype | 1.32077202 |
56 | MP0001968_abnormal_touch/_nociception | 1.30313629 |
57 | MP0006082_CNS_inflammation | 1.29824693 |
58 | MP0002572_abnormal_emotion/affect_behav | 1.29346211 |
59 | MP0001533_abnormal_skeleton_physiology | 1.29182970 |
60 | MP0003879_abnormal_hair_cell | 1.28718286 |
61 | MP0003183_abnormal_peptide_metabolism | 1.26672788 |
62 | MP0005646_abnormal_pituitary_gland | 1.24325406 |
63 | MP0003866_abnormal_defecation | 1.20709373 |
64 | MP0003828_pulmonary_edema | 1.20603263 |
65 | MP0000689_abnormal_spleen_morphology | 1.20186216 |
66 | MP0002971_abnormal_brown_adipose | 1.20159735 |
67 | MP0003763_abnormal_thymus_physiology | 1.18317676 |
68 | MP0004381_abnormal_hair_follicle | 1.16526815 |
69 | MP0000703_abnormal_thymus_morphology | 1.15549332 |
70 | MP0004215_abnormal_myocardial_fiber | 1.15009225 |
71 | MP0001502_abnormal_circadian_rhythm | 1.13970435 |
72 | MP0003787_abnormal_imprinting | 1.12648120 |
73 | MP0003075_altered_response_to | 1.11807382 |
74 | MP0002722_abnormal_immune_system | 1.09440040 |
75 | MP0002736_abnormal_nociception_after | 1.08777478 |
76 | MP0003724_increased_susceptibility_to | 1.08760438 |
77 | MP0000685_abnormal_immune_system | 1.08679412 |
78 | MP0001984_abnormal_olfaction | 1.08675122 |
79 | MP0002148_abnormal_hypersensitivity_rea | 1.07823769 |
80 | MP0001845_abnormal_inflammatory_respons | 1.07765165 |
81 | MP0002734_abnormal_mechanical_nocicepti | 1.07158965 |
82 | MP0009278_abnormal_bone_marrow | 1.06622957 |
83 | MP0008874_decreased_physiological_sensi | 1.06428984 |
84 | MP0003690_abnormal_glial_cell | 1.05467778 |
85 | MP0001800_abnormal_humoral_immune | 1.05060046 |
86 | MP0000920_abnormal_myelination | 1.03993961 |
87 | MP0004147_increased_porphyrin_level | 1.01204330 |
88 | MP0002429_abnormal_blood_cell | 1.00764995 |
89 | MP0004084_abnormal_cardiac_muscle | 1.00600629 |
90 | MP0010155_abnormal_intestine_physiology | 1.00264485 |
91 | MP0008260_abnormal_autophagy | 1.00030054 |
92 | MP0002928_abnormal_bile_duct | 0.99621051 |
93 | MP0003329_amyloid_beta_deposits | 0.98298659 |
94 | MP0002653_abnormal_ependyma_morphology | 0.97811111 |
95 | MP0002933_joint_inflammation | 0.97477436 |
96 | MP0002638_abnormal_pupillary_reflex | 0.97337556 |
97 | MP0002332_abnormal_exercise_endurance | 0.97240533 |
98 | MP0001851_eye_inflammation | 0.96300773 |
99 | MP0008872_abnormal_physiological_respon | 0.95312968 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.94263260 |
101 | MP0010386_abnormal_urinary_bladder | 0.94149932 |
102 | MP0003631_nervous_system_phenotype | 0.94132728 |
103 | MP0002735_abnormal_chemical_nociception | 0.94028048 |
104 | MP0004858_abnormal_nervous_system | 0.93912651 |
105 | MP0001970_abnormal_pain_threshold | 0.93272449 |
106 | MP0002067_abnormal_sensory_capabilities | 0.92993533 |
107 | MP0009764_decreased_sensitivity_to | 0.90623136 |
108 | MP0003303_peritoneal_inflammation | 0.90031239 |
109 | MP0000604_amyloidosis | 0.89723588 |
110 | MP0003136_yellow_coat_color | 0.89310513 |
111 | MP0002009_preneoplasia | 0.89129038 |
112 | MP0002420_abnormal_adaptive_immunity | 0.88958504 |
113 | MP0002723_abnormal_immune_serum | 0.88467800 |
114 | MP0005464_abnormal_platelet_physiology | 0.87380265 |
115 | MP0001819_abnormal_immune_cell | 0.86509417 |
116 | MP0005000_abnormal_immune_tolerance | 0.86110142 |
117 | MP0002078_abnormal_glucose_homeostasis | 0.85893464 |
118 | MP0001545_abnormal_hematopoietic_system | 0.85838178 |
119 | MP0005397_hematopoietic_system_phenotyp | 0.85838178 |
120 | MP0001486_abnormal_startle_reflex | 0.85714675 |
121 | MP0002090_abnormal_vision | 0.85251171 |
122 | MP0001958_emphysema | 0.85104447 |
123 | MP0002693_abnormal_pancreas_physiology | 0.84416101 |
124 | MP0002277_abnormal_respiratory_mucosa | 0.84316467 |
125 | MP0000465_gastrointestinal_hemorrhage | 0.84228883 |
126 | MP0002138_abnormal_hepatobiliary_system | 0.83483845 |
127 | MP0002396_abnormal_hematopoietic_system | 0.83359424 |
128 | MP0005386_behavior/neurological_phenoty | 0.83302768 |
129 | MP0004924_abnormal_behavior | 0.83302768 |
130 | MP0002733_abnormal_thermal_nociception | 0.81707213 |
131 | MP0003880_abnormal_central_pattern | 0.80486216 |
132 | MP0005551_abnormal_eye_electrophysiolog | 0.78706521 |
133 | MP0004087_abnormal_muscle_fiber | 0.78696585 |
134 | MP0009115_abnormal_fat_cell | 0.77703590 |
135 | MP0002452_abnormal_antigen_presenting | 0.77617714 |
136 | MP0004885_abnormal_endolymph | 0.77536313 |
137 | MP0004947_skin_inflammation | 0.77423904 |
138 | MP0002132_abnormal_respiratory_system | 0.76683556 |
139 | MP0002877_abnormal_melanocyte_morpholog | 0.76491007 |
140 | MP0005620_abnormal_muscle_contractility | 0.76121669 |
141 | MP0009333_abnormal_splenocyte_physiolog | 0.75111972 |
142 | MP0001873_stomach_inflammation | 0.73991225 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.86927154 |
2 | Myositis (HP:0100614) | 4.12865979 |
3 | Visual hallucinations (HP:0002367) | 3.99077817 |
4 | Papilledema (HP:0001085) | 3.95254713 |
5 | Recurrent bacterial skin infections (HP:0005406) | 3.80055407 |
6 | Focal motor seizures (HP:0011153) | 3.77573168 |
7 | Optic neuritis (HP:0100653) | 3.68502562 |
8 | Retrobulbar optic neuritis (HP:0100654) | 3.68502562 |
9 | Orchitis (HP:0100796) | 3.66556803 |
10 | Recurrent abscess formation (HP:0002722) | 3.61735453 |
11 | Stomatitis (HP:0010280) | 3.56848580 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.43637739 |
13 | Febrile seizures (HP:0002373) | 3.30875658 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27530170 |
15 | Hypochromic microcytic anemia (HP:0004840) | 3.26457698 |
16 | Focal seizures (HP:0007359) | 3.16598097 |
17 | Abnormality of the fingertips (HP:0001211) | 3.16175894 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.14826192 |
19 | Spontaneous hematomas (HP:0007420) | 3.09103243 |
20 | Meningitis (HP:0001287) | 3.05770026 |
21 | Recurrent fungal infections (HP:0002841) | 3.05146475 |
22 | Abnormality of macrophages (HP:0004311) | 3.03302928 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01005141 |
24 | Atonic seizures (HP:0010819) | 2.92213377 |
25 | Obstructive lung disease (HP:0006536) | 2.88057052 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88057052 |
27 | Dysmetric saccades (HP:0000641) | 2.88029882 |
28 | Hypothermia (HP:0002045) | 2.87956542 |
29 | Prolonged bleeding time (HP:0003010) | 2.86773749 |
30 | Vasculitis (HP:0002633) | 2.83174654 |
31 | Chest pain (HP:0100749) | 2.81665535 |
32 | Action tremor (HP:0002345) | 2.79719925 |
33 | Exercise-induced myalgia (HP:0003738) | 2.70630594 |
34 | Hypochromic anemia (HP:0001931) | 2.68705844 |
35 | Oligomenorrhea (HP:0000876) | 2.63657350 |
36 | Keratoconjunctivitis sicca (HP:0001097) | 2.61834478 |
37 | Agammaglobulinemia (HP:0004432) | 2.60970152 |
38 | Postural instability (HP:0002172) | 2.58946533 |
39 | Encephalitis (HP:0002383) | 2.56331618 |
40 | Ventricular fibrillation (HP:0001663) | 2.55920622 |
41 | Hemoptysis (HP:0002105) | 2.55791667 |
42 | Abnormality of binocular vision (HP:0011514) | 2.53240394 |
43 | Diplopia (HP:0000651) | 2.53240394 |
44 | Pulmonary infiltrates (HP:0002113) | 2.48945746 |
45 | Autoimmune thrombocytopenia (HP:0001973) | 2.48474569 |
46 | Recurrent skin infections (HP:0001581) | 2.47200677 |
47 | Myokymia (HP:0002411) | 2.46284882 |
48 | Obstructive sleep apnea (HP:0002870) | 2.45567730 |
49 | Keratoconjunctivitis (HP:0001096) | 2.44887721 |
50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44837915 |
51 | Resting tremor (HP:0002322) | 2.43954866 |
52 | Gingivitis (HP:0000230) | 2.43132560 |
53 | Progressive cerebellar ataxia (HP:0002073) | 2.42728441 |
54 | Cellulitis (HP:0100658) | 2.42583012 |
55 | Colitis (HP:0002583) | 2.41883971 |
56 | Truncal ataxia (HP:0002078) | 2.40494260 |
57 | Hemiplegia (HP:0002301) | 2.40097028 |
58 | Panhypogammaglobulinemia (HP:0003139) | 2.38871803 |
59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38827499 |
60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38827499 |
61 | Increased cerebral lipofuscin (HP:0011813) | 2.38172074 |
62 | Macroorchidism (HP:0000053) | 2.37266742 |
63 | Recurrent bronchitis (HP:0002837) | 2.34832211 |
64 | Menstrual irregularities (HP:0000858) | 2.34541051 |
65 | Pustule (HP:0200039) | 2.34189646 |
66 | Bundle branch block (HP:0011710) | 2.33083143 |
67 | Ankle clonus (HP:0011448) | 2.32716382 |
68 | Abnormality of the periventricular white matter (HP:0002518) | 2.31919469 |
69 | Pulmonary embolism (HP:0002204) | 2.29788416 |
70 | Gaze-evoked nystagmus (HP:0000640) | 2.24254107 |
71 | T lymphocytopenia (HP:0005403) | 2.24165143 |
72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.20824335 |
73 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.20655889 |
74 | Genetic anticipation (HP:0003743) | 2.19782441 |
75 | Episodic fever (HP:0001954) | 2.19644740 |
76 | Absence seizures (HP:0002121) | 2.18847406 |
77 | Hyperkalemia (HP:0002153) | 2.18786345 |
78 | Spastic gait (HP:0002064) | 2.18221671 |
79 | Asymmetric septal hypertrophy (HP:0001670) | 2.17531499 |
80 | Supranuclear gaze palsy (HP:0000605) | 2.15592585 |
81 | Abnormality of T cell number (HP:0011839) | 2.15105882 |
82 | Gastrointestinal stroma tumor (HP:0100723) | 2.13297545 |
83 | Myoglobinuria (HP:0002913) | 2.12663095 |
84 | Fatigue (HP:0012378) | 2.12603332 |
85 | Hyperventilation (HP:0002883) | 2.11733523 |
86 | Syncope (HP:0001279) | 2.11561890 |
87 | Difficulty running (HP:0009046) | 2.11241045 |
88 | Hematochezia (HP:0002573) | 2.09753807 |
89 | Papilloma (HP:0012740) | 2.09025212 |
90 | Verrucae (HP:0200043) | 2.09025212 |
91 | Generalized tonic-clonic seizures (HP:0002069) | 2.09017351 |
92 | Peripheral hypomyelination (HP:0007182) | 2.08327510 |
93 | Hyporeflexia of lower limbs (HP:0002600) | 2.07757353 |
94 | Frequent falls (HP:0002359) | 2.07089865 |
95 | Microcytic anemia (HP:0001935) | 2.06067227 |
96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05460128 |
97 | Enlarged penis (HP:0000040) | 2.04424560 |
98 | Urticaria (HP:0001025) | 2.04152437 |
99 | Decreased circulating renin level (HP:0003351) | 2.03151403 |
100 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.02968807 |
101 | Global brain atrophy (HP:0002283) | 2.02358422 |
102 | Facial diplegia (HP:0001349) | 2.02128930 |
103 | Epistaxis (HP:0000421) | 2.02038141 |
104 | Absent speech (HP:0001344) | 2.01639707 |
105 | Osteomyelitis (HP:0002754) | 2.01614610 |
106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01298092 |
107 | Intention tremor (HP:0002080) | 2.01185385 |
108 | Recurrent sinusitis (HP:0011108) | 1.99453683 |
109 | Impaired social interactions (HP:0000735) | 1.98275269 |
110 | Abnormal social behavior (HP:0012433) | 1.98275269 |
111 | Leukocytosis (HP:0001974) | 1.98003430 |
112 | Dialeptic seizures (HP:0011146) | 1.97295882 |
113 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.95715884 |
114 | Vertigo (HP:0002321) | 1.95355263 |
115 | Restrictive lung disease (HP:0002091) | 1.92435393 |
116 | Sepsis (HP:0100806) | 1.92025357 |
117 | Impaired smooth pursuit (HP:0007772) | 1.91618113 |
118 | Granulocytopenia (HP:0001913) | 1.91309241 |
119 | Increased CSF protein (HP:0002922) | 1.90866335 |
120 | Nasal polyposis (HP:0100582) | 1.90096750 |
121 | Lymphopenia (HP:0001888) | 1.89099073 |
122 | Rapidly progressive (HP:0003678) | 1.88695469 |
123 | Abnormality of saccadic eye movements (HP:0000570) | 1.87003793 |
124 | Hyperactive renin-angiotensin system (HP:0000841) | 1.86294597 |
125 | Abnormality of T cells (HP:0002843) | 1.86069977 |
126 | Dysdiadochokinesis (HP:0002075) | 1.85448044 |
127 | Inflammation of the large intestine (HP:0002037) | 1.85390442 |
128 | Prolonged QT interval (HP:0001657) | 1.84467924 |
129 | Dysmetria (HP:0001310) | 1.83263199 |
130 | Spinal canal stenosis (HP:0003416) | 1.83209119 |
131 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.83023587 |
132 | Subcapsular cataract (HP:0000523) | 1.82566285 |
133 | Stomach cancer (HP:0012126) | 1.81199412 |
134 | Acne (HP:0001061) | 1.80585727 |
135 | Slow saccadic eye movements (HP:0000514) | 1.80564052 |
136 | Arterial tortuosity (HP:0005116) | 1.80028451 |
137 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79383060 |
138 | Abnormality of the endocardium (HP:0004306) | 1.79349420 |
139 | Gingival bleeding (HP:0000225) | 1.79056817 |
140 | Gastrointestinal inflammation (HP:0004386) | 1.78620483 |
141 | Abnormal eating behavior (HP:0100738) | 1.77519872 |
142 | Truncal obesity (HP:0001956) | 1.77486209 |
143 | Chronic diarrhea (HP:0002028) | 1.77396706 |
144 | Mask-like facies (HP:0000298) | 1.77343419 |
145 | Increased IgE level (HP:0003212) | 1.76377181 |
146 | Hyperphosphatemia (HP:0002905) | 1.76297146 |
147 | Hand muscle atrophy (HP:0009130) | 1.76052884 |
148 | Growth hormone excess (HP:0000845) | 1.75983475 |
149 | Central scotoma (HP:0000603) | 1.75681240 |
150 | Dysostosis multiplex (HP:0000943) | 1.75548827 |
151 | Depression (HP:0000716) | 1.74671284 |
152 | Epileptic encephalopathy (HP:0200134) | 1.73652119 |
153 | Polycythemia (HP:0001901) | 1.72509468 |
154 | Cerebral aneurysm (HP:0004944) | 1.72245937 |
155 | Thyroiditis (HP:0100646) | 1.72005461 |
156 | Abnormality of the nasal mucosa (HP:0000433) | 1.71711873 |
157 | Urinary urgency (HP:0000012) | 1.71615594 |
158 | Poor eye contact (HP:0000817) | 1.70158024 |
159 | Pheochromocytoma (HP:0002666) | 1.70073073 |
160 | Distal upper limb amyotrophy (HP:0007149) | 1.69827470 |
161 | Upper limb amyotrophy (HP:0009129) | 1.69827470 |
162 | Acanthosis nigricans (HP:0000956) | 1.67654795 |
163 | Abnormality of chloride homeostasis (HP:0011422) | 1.66792586 |
164 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.66626343 |
165 | Lower limb asymmetry (HP:0100559) | 1.66488407 |
166 | Muscle fiber splitting (HP:0003555) | 1.65564753 |
167 | Striae distensae (HP:0001065) | 1.65465708 |
168 | Recurrent viral infections (HP:0004429) | 1.64527671 |
169 | Progressive visual loss (HP:0000529) | 1.64440817 |
170 | Neoplasm of the heart (HP:0100544) | 1.63688608 |
171 | Hypokalemic alkalosis (HP:0001949) | 1.63590597 |
172 | Arterial thrombosis (HP:0004420) | 1.63241062 |
173 | Abnormal EKG (HP:0003115) | 1.63054984 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 2.48425878 |
2 | MAP3K13 | 2.39702407 |
3 | BLK | 2.38750274 |
4 | TAOK3 | 2.24958354 |
5 | PRPF4B | 2.19441676 |
6 | NTRK3 | 2.11175706 |
7 | LMTK2 | 2.11059851 |
8 | RIPK4 | 2.00598568 |
9 | MAP3K2 | 1.98641853 |
10 | JAK1 | 1.95444544 |
11 | KSR2 | 1.88465665 |
12 | CAMK1D | 1.78547112 |
13 | DAPK2 | 1.74293215 |
14 | MAP4K1 | 1.73671516 |
15 | CAMK1G | 1.71676455 |
16 | SGK3 | 1.67051745 |
17 | MAP2K3 | 1.66639160 |
18 | PRKCH | 1.60724522 |
19 | IRAK4 | 1.59107933 |
20 | STK38 | 1.58581935 |
21 | MAP3K4 | 1.58290912 |
22 | TIE1 | 1.58116960 |
23 | ERN1 | 1.54957565 |
24 | EEF2K | 1.51609476 |
25 | SGK2 | 1.51326646 |
26 | MAP3K9 | 1.48216393 |
27 | TRIB3 | 1.48151474 |
28 | CSK | 1.45443180 |
29 | RIPK1 | 1.44197902 |
30 | BTK | 1.37350789 |
31 | TXK | 1.35746768 |
32 | FES | 1.34025849 |
33 | FGFR3 | 1.28698260 |
34 | TYK2 | 1.27322583 |
35 | INSRR | 1.20668584 |
36 | MAP3K12 | 1.20130088 |
37 | SGK494 | 1.18732609 |
38 | SGK223 | 1.18732609 |
39 | MAP3K7 | 1.18622928 |
40 | RET | 1.15738312 |
41 | TTN | 1.15722077 |
42 | FGFR2 | 1.15039210 |
43 | PDK1 | 1.14983179 |
44 | CAMKK1 | 1.07909302 |
45 | PHKG2 | 1.07381930 |
46 | PHKG1 | 1.07381930 |
47 | IKBKE | 1.05182992 |
48 | MAPK13 | 1.01763389 |
49 | STK11 | 0.99814300 |
50 | PDPK1 | 0.99752978 |
51 | WNK1 | 0.99066577 |
52 | ITK | 0.98947263 |
53 | PTK6 | 0.97457977 |
54 | MUSK | 0.94419723 |
55 | MAP2K4 | 0.93388493 |
56 | MAP2K7 | 0.93014427 |
57 | CAMKK2 | 0.92481944 |
58 | TNK2 | 0.91834551 |
59 | MAP3K11 | 0.91463644 |
60 | JAK2 | 0.91429635 |
61 | EPHA3 | 0.90886411 |
62 | DMPK | 0.90796465 |
63 | CDC42BPA | 0.90083675 |
64 | LYN | 0.89182194 |
65 | TGFBR2 | 0.89090722 |
66 | PRKD3 | 0.88031500 |
67 | MARK1 | 0.87117131 |
68 | TAOK1 | 0.86177191 |
69 | JAK3 | 0.85246681 |
70 | PRKAA2 | 0.84296824 |
71 | MAP3K1 | 0.83876487 |
72 | SIK3 | 0.83703905 |
73 | MAP3K14 | 0.83338236 |
74 | MAPK15 | 0.82088438 |
75 | AKT3 | 0.81993412 |
76 | MARK3 | 0.81635579 |
77 | MAPK7 | 0.81399593 |
78 | CDK19 | 0.79368558 |
79 | UHMK1 | 0.78930687 |
80 | MAP3K6 | 0.78025633 |
81 | SGK1 | 0.76782040 |
82 | CASK | 0.75719793 |
83 | CAMK1 | 0.73376162 |
84 | PINK1 | 0.72724670 |
85 | ZAP70 | 0.72292696 |
86 | HCK | 0.71878552 |
87 | PDK2 | 0.71776042 |
88 | PRKCQ | 0.71391883 |
89 | KIT | 0.71285683 |
90 | MAPKAPK3 | 0.70770778 |
91 | NTRK2 | 0.69911547 |
92 | PTK2B | 0.69059093 |
93 | NLK | 0.69027941 |
94 | PRKAA1 | 0.68556824 |
95 | IRAK1 | 0.67979855 |
96 | TBK1 | 0.67926195 |
97 | FGR | 0.67262802 |
98 | MAP2K6 | 0.66852608 |
99 | CAMK4 | 0.65973875 |
100 | SYK | 0.65562824 |
101 | EPHA4 | 0.65113596 |
102 | MARK2 | 0.64841952 |
103 | MAPKAPK5 | 0.64742151 |
104 | FYN | 0.64717410 |
105 | GRK5 | 0.63764358 |
106 | GRK6 | 0.63585688 |
107 | CDK5 | 0.63128338 |
108 | DYRK1B | 0.62576948 |
109 | DYRK1A | 0.62117851 |
110 | MAPK12 | 0.62042299 |
111 | PDK4 | 0.62019268 |
112 | PDK3 | 0.62019268 |
113 | RAF1 | 0.61967983 |
114 | BMPR2 | 0.61212568 |
115 | DAPK1 | 0.61144031 |
116 | PAK3 | 0.58480066 |
117 | PAK6 | 0.57868138 |
118 | MYLK | 0.57856377 |
119 | WNK4 | 0.57615092 |
120 | TRPM7 | 0.56986833 |
121 | CDK12 | 0.56699651 |
122 | TEC | 0.56519685 |
123 | RPS6KA2 | 0.56485943 |
124 | SIK2 | 0.55759370 |
125 | PRKD1 | 0.54622016 |
126 | FGFR4 | 0.54500049 |
127 | EPHB1 | 0.52209259 |
128 | MINK1 | 0.52057547 |
129 | OBSCN | 0.51661295 |
130 | PRKD2 | 0.51482792 |
131 | STK24 | 0.50886366 |
132 | IKBKB | 0.49206243 |
133 | YES1 | 0.48809493 |
134 | OXSR1 | 0.47492016 |
135 | GRK1 | 0.47483986 |
136 | LCK | 0.46827366 |
137 | HIPK2 | 0.43587165 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93826573 |
2 | Olfactory transduction_Homo sapiens_hsa04740 | 1.93265871 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82676494 |
4 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.80668161 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 1.69916151 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67856358 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 1.67126967 |
8 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.67003681 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63335648 |
10 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63146239 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62184013 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.61403499 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60961318 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 1.54732138 |
15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53650282 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 1.49567812 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.48960329 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44362063 |
19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.40833662 |
20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.39294751 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38588850 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.34475499 |
23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33490827 |
24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31785293 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31466130 |
26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30020182 |
27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28657771 |
28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25448217 |
29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25267276 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.25227539 |
31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24084462 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23040656 |
33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20494352 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20420604 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16901409 |
36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15085602 |
37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.14063732 |
38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11843656 |
39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10693583 |
40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09933460 |
41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08948292 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08813270 |
43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08348998 |
44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04844195 |
45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04788288 |
46 | Malaria_Homo sapiens_hsa05144 | 1.03276953 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00968089 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99464619 |
49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98895058 |
50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98561996 |
51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97943536 |
52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97805073 |
53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97655904 |
54 | Measles_Homo sapiens_hsa05162 | 0.95906747 |
55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95503602 |
56 | Asthma_Homo sapiens_hsa05310 | 0.95355933 |
57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93659134 |
58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93267651 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93197004 |
60 | Insulin resistance_Homo sapiens_hsa04931 | 0.92611372 |
61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91933620 |
62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90503298 |
63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89774234 |
64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89065148 |
65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88915071 |
66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88191353 |
67 | Glioma_Homo sapiens_hsa05214 | 0.87331771 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86088968 |
69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85243713 |
70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84322226 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84175536 |
72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84168957 |
73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84026930 |
74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83647275 |
75 | Long-term depression_Homo sapiens_hsa04730 | 0.83549870 |
76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82239515 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80741574 |
78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80423776 |
79 | Influenza A_Homo sapiens_hsa05164 | 0.79808035 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79755280 |
81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79181263 |
82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78672567 |
83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78604332 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78495648 |
85 | Lysosome_Homo sapiens_hsa04142 | 0.76947838 |
86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75610212 |
87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74982876 |
88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74906738 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74529915 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74491192 |
91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74053893 |
92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73554450 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73085144 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72634902 |
95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71625785 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71235899 |
97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70175580 |
98 | Phagosome_Homo sapiens_hsa04145 | 0.69903404 |
99 | ABC transporters_Homo sapiens_hsa02010 | 0.69868823 |
100 | Phototransduction_Homo sapiens_hsa04744 | 0.69801675 |
101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68457038 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68048867 |
103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67985539 |
104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67786108 |
105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67416092 |
106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67385218 |
107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66909066 |
108 | Platelet activation_Homo sapiens_hsa04611 | 0.65730883 |
109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64685573 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63773785 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63202494 |
112 | Hepatitis B_Homo sapiens_hsa05161 | 0.63031968 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.61053059 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60941682 |
115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60784384 |
116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60575948 |
117 | Bile secretion_Homo sapiens_hsa04976 | 0.60120540 |
118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59945531 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59806037 |
120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59228651 |
121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58503755 |
122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58180435 |
123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57965345 |
124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57453801 |
125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57237399 |
126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56406817 |
127 | Hepatitis C_Homo sapiens_hsa05160 | 0.55028097 |
128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54675659 |
129 | Tuberculosis_Homo sapiens_hsa05152 | 0.54217161 |
130 | Gap junction_Homo sapiens_hsa04540 | 0.53301665 |
131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52143319 |